Marc Wolff Email and Phone Number
C Suite experience in Public and Private Corporations with $15 Million to $1.5 Billion in RevenueSenior executive with extensive hands-on experience in finance, general management, operations leadership and working with Board of Directors.Versatile leader with an established record of success in significantly growing enterprise value.Comprehensive, in-depth experience across all corporate functions. Demonstrated organizational and negotiation skills. Proven success in leading global cross-functional teams across +25 pharmaceutical manufacturing, packaging & R&D, CRO sites worldwide.Leadership Experiences:• General Management & P&L Responsibility• Business Expansion, Spin Off & Start-ups• Product launches, Licensing, Contracting• International Business Management• Strong Customer Focus• Merger, Acquisitions & Divestiture Negotiations • Financial & Strategic Planning• Private Equity – Venture Capital• Complex Business & Tax Structures• Treasury functions: Debt Financing, Cashflow & w/c management• Turnaround & Crisis Management• Building High Performing Teams• Board of DirectorsHighly motivated professional with strong leadership and communication skills. Result oriented and with a broad range of competencies. Big 4 public accounting firm experience. Fluent in English, French and German.
-
Chief Executive OfficerHive & Colony ManagementDelray Beach, Fl, Us
-
Member Board Of DirectorsOncodea Feb 2023 - PresentSt Paul, Us -
Chief Executive OfficerHive & Colony Management Jan 2023 - Present
-
PartnerKineticos Disruptor Fund Dec 2021 - PresentKineticos Ventures invests in biotechs striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. The Kineticos Ventures fund focuses on significant, unmet medical needs in oncology, neurosciences, and rare diseases, utilizing disruptive technologies such as cell and gene therapy, gene editing, and mRNA/RNAi, all technologies dramatically changing how medicine is practiced
-
Board MemberJura Bio, Inc. Jun 2023 - Jul 2024Somerville, Ma, Us -
Bod MemberLacerta Therapeutics Nov 2021 - Jan 2024Alachua, Florida, UsCommitted to curing rare genetic disorders of the central nervous system. -
Chief Executive OfficerCalviri Apr 2021 - Nov 2022Phoenix, Arizona, UsCalviri’s mission is to provide affordable products worldwide that will end deaths from cancer by combining a unique, highly immunogenic source of neoantigens with a peptide array platform. On our course to eradicate cancer we will develop new diagnostic and therapeutic products, and then preventative vaccines that will stop cancer from starting. Our technology platforms provide reliable, early cancer detection solutions and therapeutic and preventative cancer vaccines. -
Chief Operating OfficerAldevron Apr 2020 - Dec 2020Fargo, North Dakota, UsGuiding strategy and global planning, customer service, IT, procurement, quality, sourcing, supply chain and global operations of the company’s facilities in Fargo, Madison, and Freiburg, Germany -
Chief Financial OfficerAldevron May 2018 - Dec 2020Fargo, North Dakota, Us -
Board MemberIntelligent Quisine May 2016 - Dec 2020
-
Executive Vice President & Chief Financial OfficerSancilio & Company Jan 2015 - Apr 2018Stuart, Fl, Us -
Chief Financial OfficerJhp Pharmaceuticals Llc Oct 2013 - Jun 2014Chestnut Ridge, Ny, UsCompleted sale of JHP Pharmaceuticals to Par Pharmaceutical. -
Chief Financial OfficerResearch Pharmaceutical Services Jun 2013 - Sep 2013Fort Washington, Pa, UsAs Chief Financial Officer, leading all financial, tax and treasury aspects of the business including accounting practices, budgeting, financial planning, financing, interface with the financial community, financial analysis, acquisitions and ventures, and monitoring of financial, tax and treasury performance.Completed sale of ReSearch Pharmaceutical Services to KKR/PRA International. -
Softgel Division Cfo & Vp&Gm Japan And AustraliaCatalent Pharma Solutions Jul 2011 - May 2013Somerset, Nj, UsDual role as global CFO Softgel Technologies as well as Vice President and General Manager Softgel Businesses in Australia and Japan responsible for the growth of the softgel business in Asia Pacific. -
Business Transformation Office Leader & Vp FinanceCatalent Pharma Solutions Apr 2007 - Sep 2011Somerset, Nj, UsFollowing the spin off from Cardinal Health, served among the Executive Leadership Team as the one point contact for all transition activities and setting up Catalent Pharma Solutions as a standalone company. -
Vp/Division CfoCardinal Health 1998 - 2007Dublin, Oh, Us -
AuditArthur Andersen Sep 1993 - May 1998
-
Audit ManagerErnst & Young 1993 - 1998London, Gb -
FuturesJp Morgan 1989 - 1990New York, Ny, Us
Marc Wolff Education Details
-
Neoma Business SchoolInternational Finance
Frequently Asked Questions about Marc Wolff
What company does Marc Wolff work for?
Marc Wolff works for Hive & Colony Management
What is Marc Wolff's role at the current company?
Marc Wolff's current role is Chief Executive Officer.
What schools did Marc Wolff attend?
Marc Wolff attended Neoma Business School.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial